Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z
  • Sa

  • Saccharomyces boulardii
    Class C
    Suitable for older persons, with specific cautions. Medicine is destroyed when used in combination with antifungal agents. Do not use for patients with impaired immune system.
  • Sacubitrilum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even moderate renal insufficiency. Do not use in combination with an ACE inhibitor.
  • Salmeteroli xinafoas
    Class A
    Suitable for older persons. Potentiates sympathomimetic effects. May cause hypokalaemia.
  • Saxagliptinum
    Class C
    Suitable for older persons, with specific cautions. Limited clinical experience of use in older persons. Not suitable for patients with hepatic insufficiency. Reduce the dose even in moderate renal insufficiency. Note danger of peripheral fluid retention.
  • Se

  • Selegilini hydrochloridum
    Class C
    Suitable for older persons, with specific cautions. Serotonergic. Reduce the dose in even mild renal insufficiency. Significant adverse effects include orthostatic hypotension, hallucinations, confusion, dyskinesia, headache, dizziness and bradycardia. Do not use together with other serotonergic preparations.
  • Sennae fructus angustifoliae
    Class D
    Avoid use in older persons. A laxative that stimulates the intestine. Can be used temporary. Risk of paralytic ileus in prolonged use.
  • Sertralini hydrochloridum
    Class C
    Suitable for older persons, with specific cautions. Serotonergic. Significant adverse effects include hyponatraemia and increased risk of bleeding. Increases risk for falls. Take interactions into account. Avoid consuming grapefruit during treatment.
  • Si

  • Simeticonum
    Class A
    Suitable for older persons.
  • Simvastatinum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in severe renal insufficiency. Possible adverse effects include muscle pain and muscular weakness. Take interactions into account. Avoid consuming grapefruit during treatment.
  • So

  • Solifenacini succinas
    Used as "UROLOGICALS"
    Class D
    Avoid use in older persons. Anticholinergic. Reduce the dose in severe renal insufficiency. Significant adverse reactions include dry mouth, constipation, urinary difficulties, confusion, cognitive disorder and QTc prolongation. Take several interactions into account. Weakens the efficacy of anti-Alzheimer´s drugs.
  • Sorbitolum
    Class A
    Suitable for older persons.
  • Sotaloli hydrochloridum
    Class D
    Avoid use in older persons. Non-selective beta blocker. Risk of QT prolongation. Requires evaluation by a specialist. Reduce the dose in even mild renal insufficiency. Significant adverse effects include bradycardia and orthostatic hypotension. Take several interactions into account.
  • Sp

  • Spironolactonum
    Used as "DIURETICS"
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in moderate renal insufficiency. Do not use in severe renal insufficiency. Note risk of hyperkalaemia.
  • Su

  • Sulfasalazinum
    Class A
    Suitable for older persons, with specific cautions. Do not use in severe renal insufficiency.
  • Sulpiridum
    Used as "PSYCHOLEPTICS"
    Class C
    Suitable for older persons, with specific cautions. Risk of QT prolongation. Regularly assess the need for pharmacotherapy. Reduce the dose in even mild renal insufficiency. Significant adverse effects include cognitive disorder, confusion, extrapyramidal symptoms, orthostatic hypotension and risk of cardiovascular events. Increases risk for falls. Non-pharmacological treatments are the first line approach in the management of behavioral and psychological symptoms of dementia.
  • Sumatriptanum
    Used as "ANALGESICS"
    Class B
    Lack of research evidence, clinical experience or efficacy among older persons. Take into account adverse effects to the heart and the cardiovascular system. It is not known if renal insufficiency affects the dosage.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.